Twice vs Three Times Weekly Training Compared for Elderly Cardiometabolic Health
A 12-week Brazilian trial tests whether training frequency shapes functional capacity and blood pressure in older adults with cardiometabolic risk.
Summary
As populations age, cardiometabolic conditions and declining physical function become increasingly common. Exercise is a proven tool, yet the optimal weekly training frequency for older adults remains unclear. This 12-week uncontrolled clinical trial from Brazil's Federal University of Santa Catarina enrolled 22 elderly participants with cardiometabolic risk factors and split them into two groups: one training twice weekly and one training three times weekly. Both groups completed combined aerobic and resistance training across three progressive mesocycles. Outcomes measured included functional capacity via the Senior Fitness Test battery and a 1000-meter walk test, blood pressure, and anthropometric markers. Data were analyzed by both intention-to-treat and per-protocol approaches. The trial aimed to clarify whether adding a third weekly session meaningfully improves health outcomes — a practical question with real implications for how clinicians prescribe exercise to aging patients.
Detailed Summary
Physical inactivity and cardiometabolic disease are closely linked in aging populations. Blood pressure rises and functional capacity declines with age, yet structured exercise can reverse or slow many of these trends. Despite strong evidence for exercise as medicine, a fundamental clinical question persists: how often should older adults with cardiometabolic risk factors train each week to maximize benefit without overburden? The PROCOR trial was designed to answer exactly that.
Conducted at the Federal University of Santa Catarina in Brazil, this 12-week uncontrolled clinical trial enrolled 22 elderly participants from the Cardiopulmonary Prevention and Rehabilitation Program (PROCOR). Participants were assigned to either two sessions per week (G2x) or three sessions per week (G3x) of combined aerobic and resistance training. The program was structured into three four-week mesocycles with progressive intensity, mimicking real-world periodized training design.
Outcomes were comprehensive: anthropometric measurements, functional capacity assessed via the validated Senior Fitness Test battery and a 1000-meter field test, and hemodynamic measurements including blood pressure via automatic equipment. Analyses used generalized estimating equations with Bonferroni post-hoc correction, and both intention-to-treat and per-protocol approaches were applied to strengthen validity.
The abstract does not report outcome data, so specific differences between the two frequency groups cannot be stated. However, the design addresses a highly relevant clinical question — whether the marginal benefit of a third weekly session justifies the added time commitment and potential fatigue burden for older adults managing cardiometabolic conditions.
Findings from this trial could directly inform exercise prescription guidelines for aging patients. If two sessions prove comparably effective, adherence barriers could be reduced. If three sessions show clear superiority, clinicians would have evidence to advocate for higher frequency programs in rehabilitation settings.
Key Findings
- Trial compared 2x vs 3x weekly combined training over 12 weeks in elderly adults with cardiometabolic risk factors.
- Functional capacity was assessed using the Senior Fitness Test battery and a 1000-meter walk test.
- Blood pressure and anthropometric markers were measured to capture hemodynamic and body composition changes.
- Three progressive four-week mesocycles were used, mimicking real-world periodized rehabilitation programming.
- Both intention-to-treat and per-protocol analyses were applied to improve result robustness.
Methodology
Uncontrolled clinical trial with 22 elderly participants randomized to twice or three-times weekly combined training over 12 weeks at a Brazilian university rehabilitation program. Outcomes included functional, hemodynamic, and anthropometric measures analyzed with generalized estimating equations and Bonferroni correction. Both intention-to-treat and per-protocol analyses were conducted.
Study Limitations
The trial is small (n=22) and uncontrolled, limiting generalizability and the ability to attribute outcomes to training frequency alone. No outcome data are reported in the abstract, so actual comparative results between groups cannot be evaluated here. Summary is based on the abstract only, as the full trial record does not include published results.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: